Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus dexmedetomidine for postoperative sedation after Stanford type A aortic dissection surgery
ChiCTR2100048540Phase 4Completed
- Sponsor
- Henan Provincial Chest Hospital
- Start
- Jul 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam, dexmedetomidine and remifentanil in aortic dissection (2 arms), sponsored by Henan Provincial Chest Hospital. Primary endpoint: Percentage of total intervention time within target or optimal RASS range. Started Jul 2021; status: completed.
02
Drugs
remimazolamdexmedetomidineremifentanil
03
Conditions
aortic dissection
Beyond the preview
Go deeper on ChiCTR2100048540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048540.